Karol Górski

478 total citations
14 papers, 359 citations indexed

About

Karol Górski is a scholar working on Molecular Biology, Geriatrics and Gerontology and Neurology. According to data from OpenAlex, Karol Górski has authored 14 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Geriatrics and Gerontology and 3 papers in Neurology. Recurrent topics in Karol Górski's work include Diabetes Treatment and Management (3 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Karol Górski is often cited by papers focused on Diabetes Treatment and Management (3 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Karol Górski collaborates with scholars based in Poland, France and Italy. Karol Górski's co-authors include Michał Wiciński, Maciej Walczak, Eryk Wódkiewicz, Bartosz Malinowski, Katarzyna Pawlak-Osińska, Maciej W. Socha, Maciej Słupski, Magdalena Nowaczewska, Przemysław Sitarek and Tomasz Kowalczyk and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Karol Górski

14 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karol Górski Poland	8	111	110	64	54	50	14	359
Eryk Wódkiewicz Poland	9	125 1.1×	116 1.1×	104 1.6×	57 1.1×	72 1.4×	12	415
Dewen Kong China	8	106 1.0×	103 0.9×	24 0.4×	39 0.7×	66 1.3×	12	553
Mohammed F. El-Yamany Egypt	11	83 0.7×	139 1.3×	64 1.0×	45 0.8×	30 0.6×	24	403
Sonia Sifuentes-Franco Mexico	8	94 0.8×	153 1.4×	111 1.7×	51 0.9×	31 0.6×	19	512
Xue-Fen Pang China	11	81 0.7×	162 1.5×	69 1.1×	35 0.6×	17 0.3×	13	468
Sherehan M. Ibrahim Egypt	12	72 0.6×	140 1.3×	61 1.0×	32 0.6×	39 0.8×	18	381
Dániel Priksz Hungary	14	46 0.4×	132 1.2×	67 1.0×	50 0.9×	26 0.5×	42	408
Samy M. Eleawa Kuwait	13	88 0.8×	194 1.8×	95 1.5×	35 0.6×	17 0.3×	23	555
Norhan M. El‐Sayed Egypt	14	67 0.6×	159 1.4×	60 0.9×	52 1.0×	18 0.4×	40	442
Kirtikar Shukla United States	16	98 0.9×	211 1.9×	70 1.1×	40 0.7×	21 0.4×	29	570

Countries citing papers authored by Karol Górski

Since Specialization

Citations

This map shows the geographic impact of Karol Górski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karol Górski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karol Górski more than expected).

Fields of papers citing papers by Karol Górski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karol Górski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karol Górski. The network helps show where Karol Górski may publish in the future.

Co-authorship network of co-authors of Karol Górski

This figure shows the co-authorship network connecting the top 25 collaborators of Karol Górski. A scholar is included among the top collaborators of Karol Górski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karol Górski. Karol Górski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Górski, Karol, Tomasz Kowalczyk, Laurent Picot, et al.. (2025). Industrial applications of Cannabis sativa (L.): Exploring its biological and nanotechnological potential. Industrial Crops and Products. 225. 120566–120566. 1 indexed citations

Górski, Karol, Tomasz Kowalczyk, Laurent Picot, et al.. (2024). The Precious Potential of the Sacred Tree Chamaecyparis obtusa (Siebold & Zucc.) Endl. as a Source of Secondary Metabolites with Broad Biological Applications. International Journal of Molecular Sciences. 25(5). 2723–2723. 3 indexed citations

Kowalczyk, Tomasz, Anna Merecz-Sadowska, Patrícia Rijo, et al.. (2022). Hidden in Plants—A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies. Cancers. 14(6). 1455–1455. 22 indexed citations

Panek, Michał, et al.. (2022). New insights into the regulation of TGF‐β/Smad and MPK signaling pathway gene expressions by nasal allergen and methacholine challenge test in asthma. Clinical and Translational Allergy. 12(7). e12172–e12172. 5 indexed citations

Karbownik, Michał Seweryn, Beata Jankowska‐Polańska, Robert Horne, et al.. (2020). Adaptation and validation of the Polish version of the Beliefs about Medicines Questionnaire among cardiovascular patients and medical students. PLoS ONE. 15(4). e0230131–e0230131. 12 indexed citations

Wiciński, Michał, Bartosz Malinowski, Paweł Szychta, et al.. (2020). Resveratrol’s Impact on Vascular Smooth Muscle Cells Hyporeactivity: The Role of Rho‐Kinase Inhibition. BioMed Research International. 2020(1). 9012071–9012071. 3 indexed citations

Wiciński, Michał, Eryk Wódkiewicz, Karol Górski, Maciej Walczak, & Bartosz Malinowski. (2020). Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury. Pharmaceuticals. 13(11). 379–379. 83 indexed citations

Wiciński, Michał, Karol Górski, Eryk Wódkiewicz, et al.. (2020). Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis. International Journal of Molecular Sciences. 21(7). 2275–2275. 33 indexed citations

Sitarek, Przemysław, Tomasz Kowalczyk, Joanna Wieczfińska, et al.. (2020). Plant Extracts as a Natural Source of Bioactive Compounds and Potential Remedy for the Treatment of Certain Skin Diseases. Current Pharmaceutical Design. 26(24). 2859–2875. 18 indexed citations

10.

Wiciński, Michał, Bartosz Malinowski, Karol Górski, et al.. (2019). Possible Effects of Proton Pump Inhibitors on Hearing Loss Development. BioMed Research International. 2019. 1–10. 6 indexed citations

11.

Wiciński, Michał, Karol Górski, Maciej Walczak, et al.. (2019). Neuroprotective Properties of Linagliptin: Focus on Biochemical Mechanisms in Cerebral Ischemia, Vascular Dysfunction and Certain Neurodegenerative Diseases. International Journal of Molecular Sciences. 20(16). 4052–4052. 31 indexed citations

12.

Wiciński, Michał, Maciej W. Socha, Bartosz Malinowski, et al.. (2019). Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events. International Journal of Molecular Sciences. 20(5). 1050–1050. 69 indexed citations

13.

Wiciński, Michał, Maciej W. Socha, Maciej Walczak, et al.. (2018). Beneficial Effects of Resveratrol Administration—Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions. Nutrients. 10(11). 1813–1813. 72 indexed citations

14.

Górski, Karol, et al.. (2013). Ocena sytuacji epizootiologicznej wścieklizny na terenie Europy w 2011 r.. Życie Weterynaryjne. 88(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact